Form 8-K - Current report:
SEC Accession No. 0001193125-24-278987
Filing Date
2024-12-16
Accepted
2024-12-16 06:08:28
Documents
14
Period of Report
2024-12-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d889180d8k.htm   iXBRL 8-K 27248
2 EX-99.1 d889180dex991.htm EX-99.1 11184
  Complete submission text file 0001193125-24-278987.txt   162523

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20241214.xsd EX-101.SCH 2842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20241214_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20241214_pre.xml EX-101.PRE 10807
16 EXTRACTED XBRL INSTANCE DOCUMENT d889180d8k_htm.xml XML 3489
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

EIN.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 241550042
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)